Related Experiment Videos
[Sinus floor augmentation with simultaneous implant insertion using recombinant human osteogenic protein-1].
H Terheyden1, S Jepsen, B Möller
1Klinik für Mund-, Kiefer-, Gesichtschirurgie, Christian Albrechts Universität zu Kiel.
Laryngo- Rhino- Otologie
|March 29, 2001
Summary
The combination of recombinant human osteogenic protein-1 (rhOP-1) with BioOss significantly enhanced bone-implant contact (BIC) and osseointegration in sinus floor augmentation. This suggests rhOP-1 may offer a clinical alternative to autogenous bone grafts.
Area of Science:
- Biomaterials Science
- Regenerative Medicine
- Oral and Maxillofacial Surgery
Context:
- Sinus floor augmentation is a critical procedure in implant dentistry.
- Achieving adequate bone regeneration and implant stability is essential for successful outcomes.
- Autogenous bone grafts are the gold standard but have limitations.
Purpose:
- To evaluate the efficacy of combining recombinant human osteogenic protein-1 (rhOP-1) with BioOss for sinus floor augmentation.
- To assess the impact on ossification and bone-implant contact (BIC) with simultaneous implant placement.
Summary:
- Maxillary sinus floors in miniature pigs were augmented with BioOss containing rhOP-1 (test) or BioOss alone (control).
- Titanium implants were placed simultaneously.
- After 6 months, test sites showed significantly higher BIC (80.0%) compared to control sites (38.6%).
Impact:
- rhOP-1 significantly enhances osseointegration and BIC in sinus floor augmentation.
- This combination demonstrates potential as a clinical alternative to autogenous bone grafts.
- Accelerated and improved bone healing observed with rhOP-1 delivery via BioOss.